Liraglutide Injection — FDA Drug Shortage

Current — Meitheal Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Liraglutide Injection (injection) from Meitheal Pharmaceuticals, Inc. with status Current. The shortage was first posted on Jul 18, 2023.

Shortage details

Status
Current
Company
Meitheal Pharmaceuticals, Inc.
Package NDC
71288-563-85
Dosage Form
Injection
Presentation
Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)
Initial Posting
Jul 18, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.